Iron Sucrose API is a pharmaceutical-grade iron(III)-hydroxide sucrose complex indicated for the treatment of iron deficiency anemia, particularly in patients with chronic kidney disease (CKD) or those unable to tolerate oral iron therapy. It provides a controlled source of bioavailable iron for hemoglobin synthesis and replenishment of depleted iron stores.
Following intravenous administration, the iron complex is taken up by the reticuloendothelial system, where iron is gradually released and incorporated into ferritin, transferrin, and hemoglobin. Iron Sucrose is widely used in nephrology, hematology, and hospital-based iron replacement therapy due to its favorable safety profile and clinical efficacy.
Manufactured under WHO-GMP-certified facilities, our Iron Sucrose API is produced using advanced pharmaceutical manufacturing technologies to ensure exceptional purity, sterility, stability, and batch-to-batch consistency. Every batch undergoes comprehensive quality testing and is supplied with Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), Technical Data Sheet (TDS), and complete regulatory documentation.
Iron Sucrose API is used in injectable pharmaceutical formulations for the treatment of iron deficiency anemia, especially in patients with chronic kidney disease and those requiring intravenous iron therapy.
Iron Sucrose delivers bioavailable iron intravenously, allowing gradual release for hemoglobin production, red blood cell formation, and restoration of depleted iron stores.
Yes. We provide CoA, MSDS, Technical Data Sheet (TDS), Product Specifications, and complete regulatory documentation with every shipment.
Yes. We supply Iron Sucrose API in commercial quantities with worldwide export support and customized packaging.
Get Bulk Quote via WhatsApp